The Center for Molecular Imaging and Therapy (CMIT) aims to create, test and develop novel radiopharmaceuticals for molecular imaging and therapy. We’re working with radiopharmaceuticals used to diagnose and treat an array of conditions like dementia, movement disorders, and many different types of cancer. We routinely produce radiopharmaceuticals manufactured under ANDAs and INDs from our own intellectual property to public-domain and proprietary radiopharmaceuticals for diagnostic and therapeutic uses.
CMIT has many other radiopharmaceuticals in our library that are not included here. CMIT can customize radiopharmaceuticals for specific needs. Please inquire, if interested.